Center for Biologics Evaluation and Research (U.S.). (2007). Guidance for industry: "lookback" for hepatitis c virus (HCV) : product quarantine, consignee notification, further testing, product disposition, and notification of transfusion recipients based on donor test results indicating infection with HCV. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER).
Chicago Style (17th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: "Lookback" for Hepatitis C Virus (HCV) : Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), 2007.
MLA (9th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: "Lookback" for Hepatitis C Virus (HCV) : Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), 2007.